Thiola EC 100 MG tablet 300S
Ended Awarded
- Contract number
- SPE2DB25FX7U3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,087
Award facts
- Contract value 100% obligated
- $6,087.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,087.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Thiola EC 100 mg tablets (300 count). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of June 24, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities nationwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively for Defense Logistics Agency contracts without specific procurement set-asides. The company's extensive portfolio includes prescription medications, over-the-counter pharmaceuticals, biologics, and medical consumables across multiple therapeutic categories. This particular delivery order for Thiola EC—a pharmaceutical product used in medical treatment—represents routine pharmaceutical procurement supporting Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FX7U3?
SPE2DB25FX7U3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FX7U3 worth?
The government has obligated $6,087 on SPE2DB25FX7U3.
Is contract SPE2DB25FX7U3 an order under another contract?
Yes. SPE2DB25FX7U3 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.
Was contract SPE2DB25FX7U3 competed?
The extent of competition for SPE2DB25FX7U3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award